Lupus Nephritis Market Research
What is Lupus Nephritis?
Lupus nephritis (LN) is an autoimmune disease caused by systemic lupus erythematosus (SLE), more commonly referred to as lupus. LN occurs when the immune system attacks the kidneys. Approximately half of patients who have SLE develop renal issues, often leading to lupus nephritis.
There are currently two drugs available to treat lupus nephritis: Benlysta and Lupkynis.
Nephrologists and Rheumatologists use these FDA-approved therapies alongside diet changes and other pharmacologic therapies to help reduce kidney damage and control inflammation in patients with LN.
Spherix Global Insights – Nephrology – Lupus Nephritis
Spherix Global Insights’ Nephrology team is a leading provider of independent syndicated Lupus Nephritis market research, insights, business intelligence & advisory services.
Spherix covers lupus nephritis and associated conditions in their RealTime Dynamix™ and Patient Chart Dynamix™ Services. Spherix’s studies publishing this year covering Lupus Nephritis include:
- RealTime Dynamix™: Lupus Nephritis (US)
- Patient Chart Dynamix™: Lupus Nephritis (US)
Spherix’s RealTime Dynamix™ service includes quarterly reports, providing an unbiased view of the competitive landscape within the lupus market.
Spherix’s Patient Chart Dynamix™ service includes patient level data detailing clinical and non-clinical patient demographics, along with rationale for treatment choices. It reveals real patient management patterns through rigorous analysis of large-scale patient chart audits.
Follow Spherix Nephrology on Social Media
Follow us for nephrology industry news, insights & analysis:
For Guests & Current Clients
For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here: